Profil
Melissa Downs is currently working as a Senior Director-External Communications at Lantheus Holdings, Inc. She previously worked as an Investor Relations Contact at Progenics Pharmaceuticals, Inc.
Aktive Positionen von Melissa Downs
| Unternehmen | Position | Beginn |
|---|---|---|
| LANTHEUS HOLDINGS, INC. | Public Communications Contact | 01.08.2020 |
Ehemalige bekannte Positionen von Melissa Downs
| Unternehmen | Position | Ende |
|---|---|---|
| PROGENICS PHARMACEUTICALS, INC. | Investor Relations Kontakt | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| LANTHEUS HOLDINGS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in New York, NY. | Health Technology |
